GSK 6853 is a potent and selective BRPF1 inhibitor. GSK 6853 exhibits >1600-fold selectivity for BRPF1 over other bromodomains (pIC50 values by TR-FRET are 8.1, 5.1/4.8 and 4.7/<4.3 for BRPF1, BRPF2/3 and BRD4 BD1/2, respectively). The structural analog of GSK 6853, GSK9311, serves as a good inactive control (125- and 185-fold reduced potency in cell-free and cell-based assays, respectively). Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.